KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,480,644 | -23.4% | 44,241 | -1.7% | 0.01% | -14.3% |
Q2 2023 | $9,763,236 | -33.7% | 45,023 | -44.6% | 0.01% | -41.7% |
Q1 2023 | $14,731,397 | +5.5% | 81,269 | +14.4% | 0.01% | +9.1% |
Q4 2022 | $13,958,181 | -9.9% | 71,034 | +3.1% | 0.01% | -21.4% |
Q3 2022 | $15,500,000 | +47.9% | 68,913 | -16.8% | 0.01% | +55.6% |
Q2 2022 | $10,483,000 | -36.0% | 82,864 | -35.9% | 0.01% | -18.2% |
Q1 2022 | $16,391,000 | -3.6% | 129,277 | -0.4% | 0.01% | 0.0% |
Q4 2021 | $17,007,000 | +8.9% | 129,823 | +1.7% | 0.01% | 0.0% |
Q3 2021 | $15,618,000 | +7.1% | 127,671 | -0.2% | 0.01% | +10.0% |
Q2 2021 | $14,580,000 | -11.9% | 127,906 | -7.1% | 0.01% | -16.7% |
Q1 2021 | $16,545,000 | +16.0% | 137,611 | -2.0% | 0.01% | +9.1% |
Q4 2020 | $14,261,000 | +39.7% | 140,376 | +6.3% | 0.01% | +22.2% |
Q3 2020 | $10,209,000 | +16.3% | 132,033 | +67.7% | 0.01% | +12.5% |
Q2 2020 | $8,777,000 | – | 78,743 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |